# Ventana Medical Systems

其 VENTANA MMR RxDx panel 伴随诊断近期已针对多种癌症类型与疗法获得欧盟 IVDR 批准，扩展了其全球组织诊断平台。

Source: https://cn.bioecon.ru/companies/ventana-medical-systems/
Updated: 2026-07-20

- 国家: United States

## 可核验事实

| 事实 | 数值 | 来源 |
| --- | --- | --- |
| 产能 | 两条自动化分配器灌装线，各自年灌装能力为400万个分配器，并预留有第三条线的空间 | https://biztucson.com/invested-to-grow/ |
| 认证 | VENTANA MMR RxDx Panel获得欧盟体外诊断法规（IVDR）认证 | https://diagnostics.roche.com/global/en/news-listing/2026/roches-ventana-mmr-rxdx-panel-companion-diagnostic-receives-ivdr-approval-across-multiple-cancer-types-and-therapies.html |
| 监管批准 | VENTANA MMR RxDx Panel作为多种癌症类型和疗法的伴随诊断获欧盟IVDR和美国FDA批准 | https://diagnostics.roche.com/global/en/news-listing/2026/roches-ventana-mmr-rxdx-panel-companion-diagnostic-receives-ivdr-approval-across-multiple-cancer-types-and-therapies.html, https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpma/pma.cfm?id=P210001, https://www.targetedonc.com/view/dostarlimab-gxly-diagnostic-panel-ventana-mm-rrxdx-panel-granted-fda-approval |
| 生产基地 | 生产设施位于亚利桑那州的Oro Valley和Marana | https://biztucson.com/invested-to-grow/ |
| 营收 | 截至 2019 年年总收入超过 10 亿美元；2006 年录得 2.38 亿美元，收购后 2008 年录得 3.76 亿（瑞士法郎） | https://saddlebagnotes.com/business/article_9668c6b3-c086-50f8-bfa8-a2355445f353.html, https://www.sec.gov/Archives/edgar/data/318771/000095012309002224/y74405exv99waw5wi.htm, https://www.sec.gov/Archives/edgar/data/889131/000095010307001638/dp06120e_sctoc.htm |

独立来源: accessdata.fda.gov, biztucson.com, diagnostics.roche.com, saddlebagnotes.com, sec.gov, targetedonc.com

## 技术

- [伴随诊断平台](https://cn.bioecon.ru/technology/companion-diagnostics-platforms/)